GGrantIndex
← Search

PIOGLITAZONE THERAPY FOR INFLAMMATORY PATHWAY COMPONENT OF INSULIN RESISTANCE

$434,089M01FY2005RRNIH

University Of California San Diego, La Jolla CA

Investigators

Linked publications, trials & patents

View original record on NIH RePORTER →
PIOGLITAZONE THERAPY FOR INFLAMMATORY PATHWAY COMPONENT OF INSULIN RESISTANCE · GrantIndex